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a b s t r a c t
Lymphoproliferative disease virus (LPDV) is an exogenous oncogenic retrovirus that induces lymphoid
tumors in some galliform species of birds. Historically, outbreaks of LPDV have been reported from
Europe and Israel. Although the virus has previously never been detected in North America, herein we
describe the widespread distribution, genetic diversity, pathogenesis, and evolution of LPDV in the
United States. Characterization of the provirus genome of the index LPDV case from North America
demonstrated an 88% nucleotide identity to the Israeli prototype strain. Although phylogenetic analysis
indicated that the majority of viruses fell into a single North American lineage, a small subset of viruses
from South Carolina were most closely related to the Israeli prototype. These results suggest that LPDV
was transferred between continents to initiate outbreaks of disease. However, the direction (New World
to Old World or vice versa), mechanism, and time frame of the transcontinental spread currently remain
unknown.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Lymphoproliferative disease virus (LPDV) is an exogenous retro-
virus that induces a neoplastic syndrome in domestic turkeys
(Meleagris gallopavo), resulting in the formation of lymphoid tumors
in multiple organs (Biggs et al., 1978). Although there is circumstan-
tial evidence of LPDV-like outbreaks occurring in domestic turkeys in
Europe prior to the 1970s, the virus was not identiﬁed as an
etiological agent of disease until 1972 in the United Kingdom
(Biggs et al., 1974). Within a few years of its recognition, LPDV
outbreaks were documented in additional European countries as
well as Israel (Biggs, 1997; Ianconescu et al., 1983). These outbreaks
remained conﬁned to the European-Middle Eastern region and the
virus has never been detected outside of this area, including North
America. Although LPDV is characterized as an oncogenic retrovirus,
it does not contain a putative viral oncogene, nor does it appear to
exert its oncogenic effects through insertional mutagenesis of a
cellular proto-oncogene; thus, the mechanism by which lymphopro-
liferative disease is induced is unknown (Chajut et al., 1991; Sarid
et al., 1994; Gazit and Yaniv, 1999).
In domestic turkeys, disease due to LPDV infection is generally
ﬁrst noted around eight to 10 weeks of age, with a variable ﬂock
mortality that can reach 25% (Gazit and Yaniv, 1999; Biggs, 1997).
The characteristic lesion of LPDV infection is a pleomorphic
inﬁltrate of lymphocytes, including lymphoblasts intermixed with
plasma cells and monocytic reticular cells in multiple tissues. The
most commonly affected organs are spleen, thymus, pancreas, and
liver, although smaller focal lesions can be present in a variety
of other tissues (Biggs, 1997). LPDV has been demonstrated
experimentally to infect both turkeys and chickens (Gallus gallus),
although not ducks or geese (species not listed; Ianconescu et al.,
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1983), suggesting that the natural host range of the virus may be
restricted to birds of the order Galliformes, which also includes
other game birds such as pheasants, quail, and grouse; however,
reports of natural LPDV infections have been limited to domestic
turkeys. Under experimental conditions, viremia occurs approxi-
mately two weeks after infection and may last for up to 10 months
(Zimber et al., 1983) and horizontal transmission can occur among
birds in close contact (McDougall et al., 1978). How the virus is
transmitted in nature (e.g., vector-borne, horizontal/vertical trans-
mission) is uncertain.
Diagnostically, the identiﬁcation of LPDV has been hampered
by the inability to isolate and propagate the virus in an appropriate
culture system, including embryonating eggs, primary cell
cultures, and established cell lines (Gazit and Yaniv, 1999). How-
ever, inoculation of naive turkeys with lymphocytes transfected
with an infectious clone resulted in the reproduction of disease
Table 1
LPDV strains recovered in the United States from 2009 to 2012 that were analyzed during the study. LPDV-positive birds that were also positive for reticuloendotheliosis virus
(REV) and/or fowlpox virus (FWPV) are indicated.
Virusa County State Date Collection methodb GenBank IDc FWPV REV
3/KS/2009 Logan Kansas 2009 Diagnostic case KC801949 ✕ ✕
12/AR/2009 Columbia Arkansas 2009 Diagnostic case KC802224 ✕ ✕
122/WV/2009 Randolph West Virginia 2009 Diagnostic case KC801950 ✕ ✕
286/WV/2009 Upshur West Virginia 2009 Diagnostic case KC801993 ✕ ✕
47/WV/2010 Upshur West Virginia 2010 Diagnostic case KC801994 ✕ ✕
183/WV/2010 Wayne West Virginia 2010 Diagnostic case KC801951 ✕ ✕
27h/SC/2011 Barnwell South Carolina 2011 Seasonal harvest KC801981 n n
28h/SC/2011 Barnwell South Carolina 2011 Seasonal harvest KC802003 n n
34h/SC/2011 Barnwell South Carolina 2011 Seasonal harvest KC801982 n n
35h/SC/2011 Barnwell South Carolina 2011 Seasonal harvest KC801983 n n
37h/SC/2011 Barnwell South Carolina 2011 Seasonal harvest KC801984 n n
38h/SC/2011 Barnwell South Carolina 2011 Seasonal harvest KC801985 n n
48h/SC/2011 Aiken South Carolina 2011 Seasonal harvest KC801986 n n
52h/SC/2011 Aiken South Carolina 2011 Seasonal harvest KC801987 n n
54h/SC/2011 Aiken South Carolina 2011 Seasonal harvest KC801988 n n
59h/SC/2011 Aiken South Carolina 2011 Seasonal harvest KC801989 n n
61h/SC/2011 Aiken South Carolina 2011 Seasonal harvest KC802004 n n
62h/SC/2011 Aiken South Carolina 2011 Seasonal harvest KC801976 n n
65h/SC/2011 Aiken South Carolina 2011 Seasonal harvest KC801990 n n
67h/SC/2011 Dorchester South Carolina 2011 Seasonal harvest KC802005 n n
68h/SC/2011 Dorchester South Carolina 2011 Seasonal harvest KC801975 n n
69h/SC/2011 Dorchester South Carolina 2011 Seasonal harvest KC801991 n n
70h/SC/2011 Dorchester South Carolina 2011 Seasonal harvest KC801992 n n
90/WV/2011 Logan West Virginia 2011 Diagnostic case KC801995 n ✕
152/GA/2011 Putnam Georgia 2011 Diagnostic case KC801952 ✕ ✕
141/CO/2012 Las Animas Colorado 2012 Diagnostic case KC801953 ✕ ✕
71/MO/2012 St. Clair Missouri 2012 Diagnostic case KC801954 ✕ ✕
95/WV/2012 Morgan West Virginia 2012 Diagnostic case KC801955
159/PA/2012 Clearﬁeld Pennsylvania 2012 Diagnostic case KC801996 ✕
163-A/NY/2012 Columbia New York 2012 Diagnostic case KC801997 ✕
163-B/NY/2012 Columbia New York 2012 Diagnostic case KC801998 ✕
165-A/ME/2012 Piscataquis Maine 2012 Diagnostic case KC801999
165-C/ME/2012 Piscataquis Maine 2012 Diagnostic case KC802000 ✕ ✕
169/MD/2012 Allegany Maryland 2012 Diagnostic case KC802001 n
196/NC/2012 Bertie North Carolina 2012 Diagnostic case KC802002 ✕
205/MO/2012 Howard Missouri 2012 Diagnostic case KC801956 n ✕
216/PA/2012 Lackawanna Pennsylvania 2012 Diagnostic case KC801957 n ✕
217/LA/2012 East Feliciana Louisiana 2012 Diagnostic case KC801958 n ✕
453/NJ/2012 Sussex New Jersey 2012 Diagnostic case KC801959 ✕
514/OH/2012 Hancock Ohio 2012 Diagnostic case KC801977 ✕ ✕
517-B/ME/2012 Cumberland Maine 2012 Diagnostic case KC801960 ✕
535/PA/2012 Blair Pennsylvania 2012 Diagnostic case KC801961 ✕
560/PA/2012 Huntingdon Pennsylvania 2012 Diagnostic case KC801962
592/MS/2012 Monroe Mississippi 2012 Diagnostic case KC801963 ✕ ✕
604-A/NH/2012 Concord New Hampshire 2012 Diagnostic case KC801964
604-B/NH/2012 Sutton New Hampshire 2012 Diagnostic case KC801965
604-C/NH/2012 Lisbon New Hampshire 2012 Diagnostic case KC801966
604-D/NH/2012 Bradford New Hampshire 2012 Diagnostic case KC801967
604-E/NH/2012 Hinsdale New Hampshire 2012 Diagnostic case KC801968
604-F/NH/2012 Dublin New Hampshire 2012 Diagnostic case KC801969
621/NC/2012 Hertford North Carolina 2012 Diagnostic case KC801978 ✕
640/IN/2012 Orange Indiana 2012 Diagnostic case KC801979 n ✕
648/WV/2012 Braxton West Virginia 2012 Diagnostic case KC801970 n ✕
652/NC/2012 Camden North Carolina 2012 Diagnostic case KC801971
654/MS/2012 Copiah Mississippi 2012 Diagnostic case KC801972 ✕
655/MS/2012 Perry Mississippi 2012 Diagnostic case KC801973 ✕ ✕
660/SC/2012 Williamsburg South Carolina 2012 Diagnostic case KC801980
667/MS/2012 Stone Mississippi 2012 Diagnostic case KC801974
FWPV¼Fowlpox virus; REV¼Reticuloendotheliosis virus; n¼not tested; ✕¼negative; ¼positive.
a Virus identiﬁcation: case number/state of collection/year of collection.
b Collection method: Diagnostic clinical case (entire bird) or seasonally harvested sample (liver only).
c Other than the index case 12/AR/2009, GenBank accession numbers refer to p31/capsid sequences.
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and the detection of the virus in blood and tissues, indicating that
LPDV is replication-competent (Gak et al., 1989; Gak et al., 1990).
Thus, similar to ‘slowly-transforming’ exogenous strains of the
related avian leukosis virus (ALV) (genus Alpharetrovirus), LPDV is a
non-oncogene-containing, replication-competent, tumorigenic
virus (Payne and Venugopal, 2000). Although a number of seminal
studies conducted in Israel and the United Kingdom provided
insights into the molecular genetics, pathogenicity, and cellular
tropism of LPDV, the extent of its genetic diversity and source of
emergence remains unknown (Chajut et al., 1992; Gak et al., 1989,
1991; Gazit et al., 1979, 1982, 1983, 1986; McDougall et al., 1978;
Yaniv et al., 1979; Zimber et al., 1983).
In January 2009, an adult female wild turkey in Columbia
County, Arkansas, was found recumbent and moribund. The turkey
died shortly thereafter and was submitted to the Southeastern
Cooperative Wildlife Disease Study (SCWDS) at the University of
Georgia for diagnostic evaluation. Grossly, this turkey had marked
splenomegaly, multiple demarcated tan foci scattered throughout
the liver, and a diffuse thickening of the proximal small intestinal
wall. Microscopically, inﬁltrating neoplastic lymphoid cells were
identiﬁed in various organs, including the spleen, liver, intestines,
kidney, pancreas, and lung. Attempts to isolate endemic oncogenic
avian viruses, including reticuloendotheliosis virus (REV), Gallid
herpesvirus 2 (GaHV-2), and ALV, in a number of avian cell lines
and speciﬁc-pathogen-free embryonating chicken eggs were
unsuccessful. To further investigate a possible viral etiology for
the lymphoid neoplasia, spleen, liver, and lung samples were
screened for LPDV by PCR targeting a region spanning the p31
and capsid (CA) genes. Proviral LPDV DNAwas detected in all three
tissues, representing the ﬁrst detection of LPDV outside of Europe
and the Middle East, and the ﬁrst natural LPDV infection in a wild
avian host.
Following this initial identiﬁcation, we attempted to determine
whether LPDV may be a widespread, yet unrecognized, pathogen
in the United States by screening select wild turkey diagnostic
cases, as well as seasonally harvested wild turkeys, for the virus. In
this report, we provide a description of natural LPDV infection in
North American wild turkeys, including basic epidemiologic pat-
terns, frequency and description of lesions associated with LPDV
infection, the co-occurrence of LPDV with other common avian
viral pathogens, and the prevalence of LPDV infection in appar-
ently healthy birds. We conducted a comparative analysis of the
proviral genome of North American LPDV and the Old World
prototype strain from Israel and mapped the insertion site of LPDV
into the host genome. We also performed a phylogenetic analysis
of proviruses recovered from birds collected from 18 states
between 2009 and 2012 with that of the Israeli prototype, and
examined the evolutionary relationship of LPDV to other retro-
viruses.
Results
Detection of LPDV within the United States and lesions observed in
diagnostic cases
Following the ﬁrst recognition of LPDV in North America, we
tested tissues from select clinically ill wild turkeys submitted to
diagnostic laboratories throughout the eastern United States for
LPDV proviral DNA. Including the prototype North American strain
(12/AR/2009), LPDV was detected in 41 wild turkeys from 18
states, stretching from Maine to Louisiana and west to Colorado
(Table 1), encompassing an area covering most of the natural
geographic distribution of wild turkeys in the United States
(Hatﬁeld and Vance, 2009). The vast majority of LPDV-positive
wild turkeys were adults (36/41; 87.8%), but ﬁve (12.2%) were
hatch-year birds. There was a near even distribution of males (19/
41; 46.3%) and females (18/41; 43.9%); sex was not determined for
four wild turkeys. Tissues from two of the 41 LPDV-positive wild
turkeys were not evaluated microscopically due to the poor post-
mortem condition of the carcass. Of the remaining 39 LPDV-
positive wild turkeys, only a small minority (6/39; 15.4%) had
microscopic lesions consistent with LPDV infection in domestic
turkeys (i.e., lymphoid neoplasia). However, as REV was also
detected in two of these birds (196/NC/2012 and 453/NJ/2012),
LPDV infection in the absence of any other detectable pathogens
was diagnosed in only four birds with neoplasia-related mortality
(12/AR/2009, 122/WV/2009, 152/GA/2011, 592/MS/2012; Table 1).
Fig. 1. Gross lesions in adult wild turkeys naturally-infected with LPDV. (A) The unfeathered skin over much of the head and neck is covered by variably-sized, proliferative
nodules, some of which contain superﬁcial crusts (arrow); (B) The skin over two digits and the plantar aspect of the foot is severely thickened with multiple folds and is
covered by dark, dry crusts; (C) The spleen (SP) is markedly enlarged (8.03.83.3 cm), a characteristic gross lesion also observed in domestic birds (see Gazit and Yaniv,
1999), (LI¼ liver); (D) The liver contains numerous, irregular, variably-sized pale foci, corresponding to aggregates of pleomorphic lymphoid cells (arrow). All scale
bars¼1.0 cm.
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The remaining 33 LPDV-positive wild turkeys were diagnosed with
other causes of morbidity or mortality in the absence of lymphoid
neoplasia, including fowlpox virus (FWPV) infection (15/39; 38.5%),
bacterial infections, including systemic or skin infections (8/39;
20.5%), trauma (2/39; 5.1%), endoparasitism (1/39; 2.6%), toxicosis
(1/39; 2.6%), or undetermined (6/39; 15.4%). In addition to the two
birds with lymphoid neoplasia that were positive for both LPDV
and REV, another 17 of the LPDV-positive turkeys (19/41; 46.3%)
also tested positive for REV proviral DNA and 12 of 41 turkeys
(29.3%) were simultaneously positive for LPDV, REV, and FWPV
(Table 1).
Of the six wild turkeys determined to have died from lymphoid
neoplasia in which LPDV was detected, ﬁve were adults and one
was a hatch-year bird. There was an even sex distribution among
male and female birds. Each of the six cases were isolated disease
events involving a single bird and all affected wild turkeys were
found in a moribund condition exhibiting non-speciﬁc clinical
signs including lethargy, disorientation, ataxia, and recumbency.
Entire carcasses from ﬁve of the birds and tissues (skin, bone
marrow, and liver) from one bird were submitted for diagnostic
examination. All ﬁve of the examined wild turkey carcasses were
emaciated. Other gross lesions included splenomegaly (3/5; 60%),
tan nodules in the liver (2/5; 40%), proliferative growths in the
unfeathered skin of the head and legs (2/5; 40%), and diffuse or
nodular thickening of the intestinal wall (2/5; 40%) (Fig. 1).
Microscopically, the ﬁve wild turkey carcasses had inﬁltrates of
neoplastic lymphoid cells in tissues from multiple organs, includ-
ing liver (5/5; 100%), kidney (4/5; 80%), lung (4/5; 80%), spleen
(3/5; 60%), gastrointestinal tract (2/5; 40%), skin (2/5; 40%), heart
(2/5; 40%), brain (1/5; 20%), adrenal gland (1/5; 20%), pancreas
(1/5; 20%), and skeletal muscle (1/5; 20%). The wild turkey for
which only tissues were submitted had similar neoplastic inﬁl-
trates in the skin and bone marrow, but not in the liver. In all
six cases, neoplastic round cells morphologically consistent with
lymphocytes (often intermixed with variable numbers of plasma
cells) formed densely cellular sheets that effaced and expanded
the underlying parenchyma (Fig. 2), concordant with lesions
observed in LPDV-infected domestic turkeys (Biggs, 1997). In some
cases, the neoplastic cells also formed coalescing nodules (most
often in skin) and perivascular aggregates. Neoplastic cell popula-
tions were generally pleomorphic and cells had scant, eosinophilic
cytoplasm and round, hyperchromatic nuclei with inapparent
nucleoli and rare to occasional mitotic ﬁgures. Occasional necrotic
foci were scattered among some of the more densely cellular areas
in some tissues, most commonly in the liver and skin. The
neoplastic lymphoid inﬁltrates were most reliably recognized in
LPDV cases with little autolysis, as poor post-mortem condition
limits detailed examination and interpretation of lesions and thus
could hinder detection of cases. There were no obvious differences
in the character, distribution, or frequency of lesions between the
four LPDV-positive and two LPDV/REV-positive turkeys with
lymphoid neoplasia.
Detection of LPDV in asymptomatic seasonally-harvested wild turkeys
To obtain preliminary insights into the prevalence of LPDV
infection in apparently healthy wild turkeys, we tested livers from
74 hunter-collected turkeys from 10 different counties in South
Carolina during 2010. Thirty-three (44.6%) of the birds tested were
positive for LPDV proviral DNA by PCR. The remaining 41 (55.4%)
were negative. Thus, nearly half of the birds tested in South
Carolina were positive for LPDV infection, suggesting widespread
prevalence within the state. None of the 74 wild turkeys were
reportedly exhibiting overt signs of disease when harvested or had
gross lesions identiﬁed during routine processing. However,
microscopic examination of tissues for evidence of neoplasia was
not performed on tissues from these birds.
Fig. 2. Tissues from adult wild turkeys naturally-infected with LPDV. (A) Kidney: The interstitium is markedly expanded and effaced by sheets of neoplastic lymphocytes
(NL). Remnant cross sections of renal tubules (RT) are completely surrounded by the neoplastic cells; (B) Liver: Most of the normal architecture is effaced by neoplastic
lymphocytes. Remnant hepatic cords (HC) are compressed and distorted; (C) Intestine: There is transmural inﬁltration, marked expansion of the lamina propria (LP) and
submucosa (SM), and multifocal perimysial expansion of underlying muscular tunics (M) by neoplastic lymphocytes; (D) Skin: The dermis is expanded and obscured by
sheets of neoplastic lymphocytes that efface adnexa and there is mild orthokeratotic hyperkeratosis of the overlying epidermis. All scale bars¼100 mm. All images stained
with hematoxylin and eosin.
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Genomic analysis of the prototype North American LPDV
The complete proviral genome of the ﬁrst LPDV case identiﬁed
in North America (12/AR/2009) was PCR-ampliﬁed from liver
tumor tissue. The proviral genome of 12/AR/2009 is 7,432 nucleo-
tides in length (including both LTRs) and is ﬂanked by two six-base
pair repeats derived from the host (CCCAGC). The length of the
LTRs, genes, and proteins are shown in Table 2. For 12/AR/2009,
the tRNATrp primer binding site is 329UGGUGACCCCGACGU-
GAU346 and the polypurine tract is 7096GGGGAGGGGGA7106,
identical to the Israeli strain of LPDV and very similar to other
alpharetroviruses (Gak et al., 1991; Whitcomb et al., 1995).
Comparison of the 12/AR/2009 genome to the prototype Israeli
strain (GenBank accession U09568) demonstrated a nucleotide
identity of 87.9%, with both viruses containing the same genomic
organization of 5′-LTR-gag-pro-pol-env-LTR-3′. Nucleotide conser-
vation among the major ORFs in the two prototypes was similar,
with pol exhibiting the highest degree of identity (90.1%), followed
by gag (88.3%), pro (88.3%), and env (86.6%). Although most genes
were of similar length, the predicted SU protein of strain 12/AR/
2009 was 47 amino acids longer than the Israeli prototype due to
an extended N-terminus. In this context, the start codon for SU in
12/AR/2009 is positioned one nucleotide downstream from the
previously identiﬁed splice acceptor site for env (Sarid et al., 1994).
Similar to members of the Alpharetrovirus genus, the pol poly-
protein of LPDV is produced by ribosomal frameshifting (Sarid
et al., 1994). However, in contrast to alpharetroviruses, the viral
protease (pro) of LPDV is also produced by a 1 ribosomal
frameshift initiated by a conserved 2447GGGAAAC2453 signal
sequence and predicted stem-loop structure, thus being more
similar to betaretroviruses in this instance (Sarid et al., 1994;
Gruber et al., 2008; Stoye et al., 2011). In conjunction with pro not
being expressed as part of gag as it is in other alpharetroviruses,
the LPDV protease contains an Asp-Thr-Gly active site rather than
the thermodynamically less stable and less active Asp-Ser-Gly
triplet (Ingr et al., 2003). Comparison of the pol polyprotein
[reverse transcriptase (RT) and integrase (IN) proteins; 850 amino
acids] of the North American prototype of LPDV to other retro-
viruses demonstrated that it shared the highest amino acid
identity to the Israeli LPDV prototype (92.9%), followed by Rous
sarcoma virus (RSV) (44.0%) and ALV (43.7%), in accordance with
the phylogenetic analysis of pol (see Evolutionary analysis of LPDV
below). Other LPDV proteins that are generally more conserved
among the retroviruses, such as the CA and matrix (MA) proteins,
also shared similar levels of amino acid identity as pol to other
alpharetroviruses, although the nucleocapsid (NC; 98 amino acids)
of LPDV exhibits a moderate amino acid identity (38.7%) to simian
immunodeﬁciency virus (SIV) from NC residues 6–96, including
similar zinc ﬁnger (Cys-X2-Cys-X4-His-X4-Cys) motifs. Thus,
although LPDV is most closely related to other avian oncogenic
viruses of the genus Alpharetrovirus, it shares some identiﬁable
characteristics with other closely related genera (i.e., Betaretrovirus
frameshift strategies and Lentivirus NC homology).
A functional role for the p31 protein of LPDV (located between
the MA and CA proteins) (Table 2) has not previously been
ascribed (Sarid et al., 1994). However, two putative L domain
motifs (PTAP and PPXY) separated by 11 amino acids were
identiﬁed near the N-terminus, suggesting that p31 may recruit
cellular factors that mediate budding of virions from infected cells
(Freed, 2002; Pincetic and Leis, 2009). Additionally, the C-terminus
of p31 in LPDV contains an LTDWGLVATE motif similar to that of
the RSV p10 protein that has been demonstrated to be critical for
immature particle assembly, suggesting that p31 may also interact
with CA (Philips et al., 2008). The only large gap in the proviral
genome sequence between the North American and Israeli LPDV
prototypes was found in the U3 region of the LTR, where the
approximate equivalent of nucleotide positions 21 to 49 (or 24 to
52) in the Israeli strain was missing in 12/AR/2009. Although this
missing stretch of nucleotides is just upstream of direct repeat
elements shown to be essential for efﬁcient transcription, deletion
of the distal 5′ end of U3 in LPDV (which includes parts of the
missing region) has been shown to increase transcriptional activ-
ity, suggesting that this region may act as a negative regulatory
element (Sarid et al., 1995).
LPDV integration
Mapping of the insertion site of the North American prototype
strain (12/AR/2009) demonstrated that it was integrated, in
reverse orientation, at nucleotide position 45,329,568 in chromo-
some 6 of the turkey genome (GenBank accessions NC_015016.1
and ADDD01042526), approximately 10.6 kB downstream of a C–C
chemokine receptor type 4-like protein and 4.2 kB upstream of a
beta-galactosidase-like protein. Although no known gene function
has yet to be ascribed to the genomic region in which the provirus
was integrated, BLAST analysis (using a Class Aves search set in the
nucleotide collection database) of the integration site demon-
strated the closest match was to a known oncogene, a serine/
threonine kinase receptor-associated protein (GenBank accession
XM_003202477), albeit only to the very 3′-terminus of the mRNA
(Datta et al., 1998; Halder et al., 2006). Currently, it is unclear
whether insertion at this site is related to the fatal oncogenesis
observed in this case.
As both LPDV and FWPV were simultaneously detected in
multiple birds (Table 1), we analyzed a subset of these cases to
determine whether LPDV may be inserted into the genome of
FWPV, similar to that observed with REV (Hertig et al., 1997).
Although both LPDV and FWPV could be PCR ampliﬁed from
original tissue samples, only FWPV could be detected after passage
in avian cell culture, indicating that the isolated poxviruses did not
contain LPDV sequences. This ﬁnding suggests that, in these cases,
either the detection of both viruses is due to temporally distinct
infections (e.g., LPDV integration into the host genome during a
former infection followed by the diagnosis of an active FWPV
infection) or that these were concomitant infections without
recombination occurring between the two viruses.
Table 2
Genomic characteristics of the North American prototype strain of LPDV.
Gene/domain Region nt aa MW pI Position
U3 5′ LTR 207 n n n 1–207
R 5′ LTR 22 n n n 208–229
U5 5′ LTR 96 n n n 230–326
Matrix (MA) gag 459 153 16.67 5.12 384–842
p31 gag 708 236 25.78 5.14 843–1550
Capsid (CA) gag 699 233 25.55 8.96 1551–2249
Nucleocapsid (NC) gag 294 98 10.18 10.78 2250–2543
Protease (PR) pro 444 148 15.98 8.87 2450–2893
Reverse transcriptase (RT) pol 1743 581 65.34 6.75 2887–4629
RT domain pol 834 278 n n 2887–3720
Tether (t) domain pol 519 173 n n 3721–4239
RNase H domain pol 390 130 n n 4240–4629
Integrase (IN) pol 810 270 30.10 9.92 4630–5439
Surface (SU) env 972 324 35.99 9.20 5459–6430
Transmembrane (TM) env 660 220 24.84 6.21 6431–7090
U3 3′ LTR 207 n n n 7107–7313
R 3′ LTR 22 n n n 7314–7335
U5 3′ LTR 97 n n n 7336–7432
MW¼molecular weight (kDa); pI¼ isoelectric point (pH); n¼not applicable.
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Evolutionary analysis of LPDV
To determine the evolutionary relationships among the North
American viruses, as well as to the prototype Israeli strain
(GenBank accession U09568), we performed a phylogenetic ana-
lysis on the newly identiﬁed proviruses recovered from birds
collected from 18 states between 2009 and 2012 (Table 1) using
a portion of the gag polyprotein (partial p31/partial CA; 413 nt).
A nucleotide and amino acid alignment of the sequences used to
infer the p31/CA phylogeny is shown in Supplementary Fig. 1. We
also conducted a phylogenetic analysis of a subset of 15 proviruses
using both a larger internal gene product [partial p31/full-length
CA (977 nt)] and an external protein [partial surface (SU) glyco-
protein; 530 nt] to determine if this provided greater resolution
between the viruses or identiﬁed differences not observed in the
partial p31/partial CA tree. Both the partial p31/full-length CA and
SU trees had similar topologies to the 413 nt p31/CA phylogeny
(data not shown; trees available from the authors on request).
Sequences used in the inference of all three phylogenies have been
deposited in GenBank under the accessions KC801949-KC802005
(p31/CA) and KC802006-KC802018 (SU).
The p31/CA phylogeny revealed the proviruses from North
America could be grouped into two major clades, termed clades
1 and 2 (Fig. 3). A small subset of four viruses from South Carolina
(62 , 67 , 68 , 69h/SC/2011) was shown to cluster with the
Israeli prototype strain of LPDV in clade 2. Remarkably, while these
four viruses exhibited between 83 and 87% nucleotide identity in
their p31/CA sequences to other viruses from the United States,
they shared a 97% identity to the Israeli virus. In contrast, the
majority of the proviruses sampled in the United States were
divergent from the Israeli strain and fell into clade 1. Although this
clade showed some evidence of geographical clustering, these
groupings were weak, as there was little phylogenetic resolution
among strains (i.e., low bootstrap support values), indicative of
relatively widespread viral gene ﬂow. The overall lack of temporal
structure in the data precluded a molecular clock dating analysis.
To better deﬁne the evolutionary relationship of LPDV to other
retroviruses, we performed a phylogenetic analysis of LPDV with
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514/OH/2012
47/WV/2010
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560/PA/2012
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604-F/NH/2012
27h/SC/2011
65h/SC/2011
34h/SC/2011
667/MS/2012
165-C/ME/2012
163-B/NY/2012
604-D/NH/2012
141/CO/2012
95/WV/2012
90/WV/2011
216/PA/2012
28h/SC/2011
3/KS/2009
196/NC/2012
61h/SC/2011
159/PA/2012
654/MS/2012
70h/SC/2011
52h/SC/2011
62h/SC/2011
592/MS/2012
122/WV/2009
163-A/NY/2012
652/NC/2012
286/WV/2009
604-E/NH/2012
12/AR/2009
67h/SC/2011
648/WV/2012
183/WV/2010
640/IN/2012
35h/SC/2011
38h/SC/2011
535/PA/2012
655/MS/2012
59h/SC/2011
660/SC/2012
453/NJ/2012
604-C/NH/2012
U09568/Israel/1978
37h/SC/2011
205/MO/2012
68h/SC/2011
621/NC/2012
169/MD/2012
604-A/NH/2012
69h/SC/2011
71/MO/2012
0.025 subs/site
Clade 1
Clade 2100
100
Fig. 3. Phylogenetic tree of p31/capsid sequences of LPDV strains recovered fromwild turkeys in the United States during 2009–2012, along with the prototype Israeli strain
from 1978 (highlighted with an asterisk). Bootstrap support values are shown for key nodes and all horizontal branch lengths are drawn to a scale of nucleotide substitutions
per site. The tree is mid-point rooted for purposes of clarity only. The 58 viruses used to infer the tree are designated as case number, followed by state and year of collection
(as shown in Table 1).
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representative members from each of the seven genera of Retro-
viridae, encompassing both Orthoretrovirinae and Spumaretrovir-
inae subfamilies, using conserved domains in RT within the pol
polyprotein (Xiong and Eickbush, 1990). The amino acid RT
phylogeny demonstrated that the North American and Israeli
LPDV prototypes grouped with ALV and RSV within the Alphare-
trovirus clade with strong (85% bootstrap) support (Fig. 4), thereby
demonstrating that LPDV is most closely related to other onco-
genic alpharetroviruses. Recently, a wide diversity of lineages of
avian endogenous retroviruses (ERV) has been identiﬁed in galli-
form (chicken, turkey) genomes that have properties characteristic
of alpha-, beta-, and gammaretroviruses, with LPDV being similar
to some avian beta-like ERVs (Bolisetty et al., 2012). However, as
alpharetroviruses are postulated to have evolved from beta-like
precursors (Bolisetty et al., 2012), that LPDV retains some betar-
etrovirus properties (i.e., frameshift strategies) while also posses-
sing alpharetrovirus motifs (e.g., tRNATrp primer binding site) and
clearly showing similar host associations (galliform birds) and a
strong phylogenetic relationship with exogenous alpharetro-
viruses (ALV and RSV), suggests that its designation as an alphar-
etrovirus is the most appropriate given current data.
Discussion
This report is the ﬁrst documentation of LPDV in the United
States and provides the ﬁrst description of the disease in naturally-
infected wild birds, along with its genetic and phylogenetic
relationship to viruses recovered in Israel in the 1990s. Although
the broad geographical distribution of the virus (Maine to Louisi-
ana and west to Colorado), coupled with the non-migratory nature
of wild turkeys, tentatively suggests that LPDV may have been
endemic in the United States for a considerable time, it is unclear if
management practices such as the extensive intra- and interstate
translocation of wild turkeys through restoration projects (Tapley
et al., 2005) may have inadvertently facilitated the more recent
Fig. 4. Family-wide phylogeny of exogenous retroviruses based on conserved protein domains in reverse transcriptase. The clade containing LPDV and representing the
Alpharetrovirus genus is shaded in blue. Bootstrap support values are shown for key nodes and all horizontal branch lengths are drawn to a scale of amino acid substitutions
per site. The tree is mid-point rooted for purposes of clarity only. Viruses (and their GenBank accession numbers) used to infer the phylogeny were: ALV, Avian leukosis virus
(ADO01000); BLV, Bovine leukemia virus (ACR15158); BFV, Bovine foamy virus (AAN08116); CAEV, Caprine arthritis encephalitis virus (AAG48629); EIAV, Equine infectious
anemia virus (AAG02702); FeLV, Feline leukemia virus (BAM45657); FIV, Feline immunodeﬁciency virus (AAB49923); FFV, Feline foamy virus (NP_056914); GALV, Gibbon ape
leukemia virus (AAC80264); HIV-1, Human immunodeﬁciency virus 1 (BAF32463); HTLV-2, Human T-lymphotropic virus 2 (AAB59885); HTLV-1, Human T-lymphotropic virus 1
(AAB20769); LPDV, Lymphoproliferative disease virus [KC802224 (USA) and U09568 (Israel)]; MMTV, Mouse mammary tumor virus (P03365); REV, Reticuloendotheliosis virus
(ABD46829); RSV, Rous sarcoma virus (CAA48535); SFV, Simian foamy virus (AFX98084); SMRV, Squirrel monkey retrovirus (NP_041261); SRV-1, Simian retrovirus 1
(ADI76909); WDSV, Walleye dermal sarcoma virus (NP_045937); WEHV-1, Walleye epidermal hyperplasia virus 1 (AAC59310); WEHV-2, Walleye epidermal hyperplasia virus 2
(AAD30054). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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spread of the virus. Additionally, because the full extent of the host
range of LPDV (which may include additional wild galliform birds
or even avian species within other orders) and the route of virus
transmission in nature (e.g., direct contact, arthropod-borne,
vertical/horizontal transmission) have not been clearly deﬁned,
whether this apparent endemicity in the United States predates
the emergence of LPDV (or recognition of LPDV-like disease) in
Europe is uncertain. Nevertheless, our analysis shows that LPDV is
widespread in the wild turkey population in the United States, is
responsible for sporadic fatal tumorigenic disease, and has likely
been missed as the etiological agent in undiagnosed cases of
lymphoid hyperplasia and neoplasia.
Although fatal tumorigenesis was attributable to LPDV infec-
tion in only four of 41 LPDV-positive birds (9.8%), this may be a
conservative estimate. Other birds had lesions that were consis-
tent with LPDV infection (e.g., multicentric neoplasia, multi-organ
lymphoplasmacytic cellular inﬁltrates), but concurrent infection
with other agents (e.g., REV, FWPV, bacteria) and the observation
of additional lesions in these birds precluded a deﬁnitive diagnosis
of LPDV infection as the cause of death. Presently, in the dual
LPDV/REV-positive cases in which fatal tumorigenesis were
observed, it is unclear which virus was responsible for the
neoplasia. However, as one of our current objectives is the
production of recombinant LPDV proteins for use as antigen in
the development of speciﬁc antisera for immunohistochemistry,
this (in conjunction with REV-speciﬁc antisera) will likely aid in
providing a more deﬁnitive diagnosis in such cases. The high
prevalence of viral co-infections in the diagnostic cases tested (i.e.,
46.3% and 36.6% of LPDV-positive birds were also positive for REV
or FWPV, respectively) further demonstrates that screening for
multiple pathogens should be performed to deﬁnitively assess the
cause(s) of mortality. Although the integration of complete or
partial REV genomes into FWPV (including vaccine strains) has
been extensively demonstrated (Hertig et al., 1997; Liu et al.,
2009), we did not detect LPDV incorporation within FWPV
genomes in dually-infected turkeys, possibly suggesting that the
association between the two viruses may be due to the persistence
of LPDV DNA in previously infected but recovered birds, such that
the two infections may commonly occur independently. However,
the potential spread of LPDV in nature via integration into FWPV
genomes, similar to that of REV, merits further investigation, as
does the potential synergistic pathological effects of coinfection of
LPDV with other pathogens.
The mechanism by which LPDV induces oncogenesis in its
turkey host is unknown. Unlike RSV, LPDV does not carry an
oncogene within its genome. However, LPDV is similar to the
related ALV, as both viruses induce tumors in galliform birds
independent of a transducing viral gene. In the case of ALV,
although viral integration is a random process, insertion in the
vicinity of the c-myc proto-oncogene has been demonstrated to
lead to tumorigenesis (Neel et al., 1981; Hayward et al., 1981).
Additionally, retroviral insertion into tumor-suppressor genes can
be oncogenic, although this generally requires that both alleles be
inactivated (e.g., Hicks and Mowat, 1988). Mapping of the insertion
site of 12/AR/2009 demonstrated that it was integrated, in reverse
orientation, into chromosome 6 of the turkey genome in a region
of unknown function downstream of a C–C chemokine receptor
type 4-like protein and upstream of a beta-galactosidase-like
protein. Although LPDV integration into the turkey genome may
be a random process, whether oncogenesis is triggered by inser-
tion into a speciﬁc region, similar to ALV and c-myc, is currently
unclear. As such, future research will be aimed at mapping the
genomic integration site of a comprehensive set of proviruses in
birds that were deemed to be unequivocal cases of LPDV-induced
tumorigenesis, as well as other birds that died of apparently
unrelated causes.
Other than the prototype Israeli strain, the lack of other
sequences from historic LPDV outbreaks from Europe and Israel
prohibits a detailed phylogenetic analysis of Old and New World
viruses. However, it was striking that a subset of four proviruses
sampled in South Carolina in 2011 (62 , 67 , 68 , 69h/SC/2011)
were more closely related genetically to the Israeli virus than to
other North American viruses, forming a distinct monophyletic
group in the p31/CA phylogeny (Clade 2 in Fig. 3), as well as in the
full-length CA or partial SU trees (data not shown). This grouping
of South Carolina and Israeli isolates provides a direct link
between viruses circulating in North America to those that ﬁrst
emerged in Europe, demonstrating that LPDV has been transferred
between continents to result in outbreaks of disease. Despite their
close evolutionary relationship, the route (North America to
Europe or vice versa), approximate time frame, and mechanism
by which the transcontinental spread of LPDV occurred is uncer-
tain. However, if wild turkeys are the predominant natural host of
the virus, and as their native range is exclusive to North America, it
is possible that LPDV originated in North America and may have
been inadvertently transferred to the Old World by the intercon-
tinental movement of infected birds. Additionally, as no recent
cases of LPDV have been detected in either Israel (personal
communication, Irit Davidson, Kimron Veterinary Institute, Bet
Dagan, Israel) or the United Kingdom (personal communication,
Venugopal Nair, Pirbright Institute, Surrey, England), the sudden
emergence of LPDV in the Old World followed by its apparent lack
of endemic circulation or recurrent disease outbreaks is again
compatible with the outbreak viruses originating from an exotic
source. However, the evolutionary origins of LPDV and its precise
transcontinental movements are currently unclear and will beneﬁt
from both retrospective and prospective analysis of additional
viruses from the Middle East, Europe, and North America.
Whether the apparent widespread nature of LPDV in the United
States is indicative of the recent identiﬁcation of a long overlooked
or misdiagnosed pathogen, or whether LPDV represents a newly
emerging virus is uncertain. Tumorigenic diseases of unknown
etiology have long been recognized in wild birds, including galli-
forms (Drew, 2007), suggesting that a long-standing failure to
detect the virus is plausible. However, it is important to note that
the population structure of wild turkeys within the United States
over the last 50 years or so has undergone dramatic changes.
Restoration projects, involving the movement of tens of thousands
of birds across the United States to boost dwindling population
numbers, have substantially altered the population demographics
of turkeys by displacing birds into new territories (Tapley et al.,
2005). Although there is no evidence that these restoration
projects have facilitated the rapid spread of the virus, the recogni-
tion of the emergence of viral diseases into new areas after the
inadvertent translocation of infected wildlife is not novel, as
epitomized by the rapid expansion and movement of raccoon
rabies throughout the northeastern United States in the 1980'–
1990s after the translocation of infected animals originating from
the southeast during the 1970s (Rupprecht and Smith, 1994).
LPDV is currently not listed as a recognized viral species by the
ICTV (Stoye et al., 2011). However, based on the genetic and
evolutionary data presented here (Fig. 4), in addition to previous
phylogenetic analyses of Israeli viruses (Chajut et al., 1992; Gazit
and Yaniv, 1999), LPDV is clearly most closely related to avian
leukosis-sarcoma viruses such as ALV and RSV. Accordingly, we
suggest that it should be designated as a new species within the
genus Alpharetrovirus, subfamily Orthoretrovirinae, family Retro-
viridae. Despite the apparent widespread geographic prevalence of
the virus among wild turkeys, LPDV does not currently appear to
be a serious threat to the North American poultry industry.
However, this is conjectural until surveillance efforts have been
made to screen commercial poultry for the presence of the virus
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and clinical trials are performed to deﬁnitively assess its patho-
genic potential. As LPDV-associated lesions can superﬁcially
resemble other retroviral (e.g., reticuloendotheliosis) and non-
retroviral (e.g. avian pox) diseases that are endemic to North
America, in addition to our observation that dual infections with
LPDV and these and other pathogens may be common, LPDV
should be considered as a potential disease agent in both retro-
spective and prospective cases of leukocytic neoplastic or hyper-
plastic disease of unknown etiology.
Materials and methods
Sample collection and virus testing
Following the ﬁrst identiﬁcation of LPDV in a North American
wild turkey, we actively targeted the collection of tissues from
clinically ill wild turkeys submitted to veterinary diagnostic
laboratories throughout the eastern United States during 2009–
2012. Samples were acquired from the diagnostic services at the
SCWDS, the New York State Department of Environmental Con-
servation, the University of Maine Animal Health Laboratory, and
the New Hampshire Veterinary Diagnostic Laboratory. These
turkeys were submitted as entire carcasses and are designated as
‘diagnostic cases’. Where possible, we targeted wild turkeys with
gross or microscopic lesions consistent with the historical descrip-
tion of LPDV infection in domestic turkeys (see McDougall et al.,
1978; Zimber et al., 1983; Biggs, 1997) and/or proliferative skin
lesions. Tissue samples acquired from diagnostic cases for LPDV
testing varied, but when possible, efforts were made to test tissue
collected directly from nodular lesions and/or lymphoid tissues.
Unless stated otherwise, tissues from all diagnostic cases were
examined by necropsy and ﬁxed in 10% neutral-buffered formalin
and processed for histopathological examination by standard
hematoxylin and eosin staining. In certain cases, special histo-
pathologic stains and ancillary diagnostic tests were performed as
noted to assess for additional infectious agents such as bacteria,
fungi, and other viruses. A diagnosis of LPDV infection as the sole
cause of death was made when (i) lymphoid inﬁltrates were
detected in multiple tissues, (ii) those tissues were PCR-positive
for LPDV, and (iii) other potential etiologies (e.g., bacteria, fungi, or
other viruses) or alternative non-microbial causes of mortality
(trauma, toxicosis) were not detected.
DNA was extracted from tissues in which lesions were observed
using a QIAamp DNA mini kit (Qiagen, Valencia, CA) according to
the manufacturer's guidelines. LPDV PCR was performed using
primers based on the Israeli prototype strain of LPDV that covered
a region spanning the p31 and CA genes (5′-ATGAGGACTTGTTA-
GATTGGTTAC-3′, 5′-TGATGGCGTCAGGGCTATTTG-3). PCR products
were ampliﬁed using a GoTaqs Flexi DNA polymerase system
(Promega, Madison, WI) and puriﬁed products were labeled for
sequencing using the ABI PRISM BigDye Terminator Cycle Sequen-
cing Ready Reaction Kit (Applied Biosystems, Foster City, CA). All
FWPV and REV cases were conﬁrmed by PCR from tissue as
previously described (Lüschow et al., 2004; Zavala et al., 2006)
and also by histopathological examination of tissues. To determine
if LPDV was incorporated into the genome of FWPV in birds where
both viruses were detected, lesions that were PCR-positive for both
viruses were mechanically homogenized in minimal essential
media (Sigma-Aldrich, St. Louis, MO), clariﬁed by centrifugation
(6700 g for 10 min), and an aliquot (100 μl) was inoculated into
DF-1 chicken ﬁbroblast (CRL-12203), ConA-B1-VICK chicken T
lymphocyte (CRL-12357), and/or Peking duck embryo ﬁbroblast
(CCL-141) cell cultures maintained at 37 1C in a 5% CO2 atmosphere.
Cell lines were obtained from the American Type Culture Collection
(ATCC; Manassas, VA). Each case was serially passaged at weekly
intervals and then DNA was extracted from cell culture supernatant
and screened for both LPDV and FWPV as stated above.
In addition to diagnostic cases, we acquired liver samples from
74 adult wild turkeys harvested in South Carolina during the 2011
spring hunting season. The 74 samples were acquired from
10 counties (Aiken, Anderson, Barnwell, Chesterﬁeld, Darlington,
Dorchester, Florence, Hampton, Marion, and Orangeburg). Liver
samples were processed and tested for LPDV as in the diagnostic
cases. These turkeys are designated as ‘seasonally harvested’ birds.
Genomic sequencing
The complete proviral genome of the index North American
case of LPDV (strain 12/AR/2009) was PCR ampliﬁed from lung
tumor tissue (deposited as GenBank accession number KC802224).
Primers for genomic sequencing were developed based on the
Israeli prototype strain (GenBank accession number U09568). Gaps
in the genome due to areas of divergence were ﬁlled in using
primers based on newly acquired sequences when necessary.
Primers are available from the authors upon request. PCR products
were cloned using a PCR Cloning Kit (Qiagen) and contigs were
assembled using Sequencher 4.1 (Gene Codes Corporation, Ann
Arbor, MI), resulting in the full-length provirus. Mapping of the
integration site of 12/AR/2009 into the turkey genome was
performed by retroviral LTR arbitrarily primed PCR (RELAP-PCR)
(Casper et al., 1998). RNA secondary structures were predicted
using the RNAfold program (Gruber et al., 2008). Percent identities
of genes and proteins among LPDV isolates and between different
retroviruses were determined using the percent identity matrix in
Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/). Theo-
retical molecular weights and isoelectric points of LPDV proteins
were predicted using the Compute pI/MW tool in the ExPASy
Bioinformatics Resource Portal (http://web.expasy.org/compu
te_pi/).
Phylogenetic analysis
We performed a phylogenetic analysis on the p31/capsid (CA)
sequences (413 nt) of all LPDV strains recovered from wild turkeys
in the United States during 2009–2012, combined with the
prototype Israeli strain recovered in 1978. The 58 new proviruses
used to infer the p31/CA tree were recovered from 58 individual
birds (41 diagnostic cases and 17 seasonally harvested birds) and
are designated as case number, followed by state and year of
collection (as shown in Table 1). A maximum likelihood (ML)
phylogeny was then estimated using PhyML 3.0 (Guindon et al.,
2010) and employing the GTRþΓ4 model of nucleotide substitu-
tion (estimated Γ shape parameter of 0.549). The best tree was
chosen after a combination of NNI and SPR branch-swapping. To
infer support for individual nodes, a bootstrap analysis was
conducted using 1000 replicate ML trees, again estimated using
the GTRþΓ4 substitution model (optimized for each run) and with
NNI branch-swapping. An equivalent phylogenetic analysis was
performed on a subset of 15 proviruses using (i) partial p31/full-
length CA (sequence alignment of 977 nt) and (ii) partial surface
(SU) glycoprotein (sequence alignment of 530 nt). All analyses
were undertaken using the same ML methods as described above.
To determine the evolutionary relationship of LPDV to other
extant retroviruses, we conducted an additional phylogenetic
analysis using conserved regions of the pol polyprotein [reverse
transcriptase (RT)]. Accordingly, conserved domains in RT (Xiong
and Eickbush, 1990) were compiled for 21 retroviruses represent-
ing the genera Alpharetrovirus, Betaretrovirus, Deltaretrovirus, Epsi-
lonretrovirus, Gammaretrovirus, Lentivirus and Spumavirus. These
sequences were combined with two LPDV sequences representing
the Israeli (U09568) and North American (12/AR/2009) prototype
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strains and aligned using MUSCLE (Edgar, 2004). Because of the
large number of insertions/deletions and alignment uncertainties,
we used Gblocks (Talavera and Castresana, 2007) to purge all such
regions prior to phylogenetic analysis. This resulted in a ﬁnal
sequence alignment of 23 taxa, 191 amino acid residues in length.
Phylogenetic analyses of these data were again undertaken using
the ML method available in PhyML 3.0, this time employing the
WAGþΓ4 model of amino acid substitution (estimated Γ shape
parameter of 1.110), and selecting the best tree after a combination
of NNI and SPR branch-swapping. A bootstrap resampling analysis
was conducted using 1000 replicate ML trees, again inferred using
the WAGþΓ4 substitution model and NNI branch-swapping.
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